Israeli AI surgical intelligence co Theator raises $15.5m
Theator s AI-powered platform is based on smart annotation and cutting edge.
Israeli AI surgical intelligence platform company Theator today announced that it has completed a $15.5 million oversubscribed Series A financing round led by Insight Partners, with new investor Blumberg Capital, and existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels. Notable individual investors including 23andMe s cofounder and CEO Anne Wojcicki, former Netflix CPO Neil Hunt, and Zebra Medical Vision s cofounder Eyal Gura also participated in the round.
The round will be used by Theator to expand commercial operations and partnerships with US providers, enlarge its R&D team and consolidate its status as a leading provider of AI-powered surgical intelligence solutions to improve the performance of surgeons. Theator has raised $18.5 million to date.
Theator Nabs $15.5M to Scale AI-Driven Surgical Intelligence Platform
What You Should Know:
– Theator raises $15.5M in Series A funding to support the company’s mission of using AI and computer vision to eradicate disparity and variability in surgical care.
– The startup plans to use this round to scale its commercial operations and partnerships with U.S. providers, grow its R&D team and cement its status as a world-leading provider of AI-powered Surgical Intelligence solutions.
Theator, a Palto Alto, CA-based Surgical Intelligence platform leveraging AI and computer vision to improve surgeon performance, today announced that it has raised $15.5M in an oversubscribed Series A round led by Insight Partners, joined by new investor Blumberg Capital, and supported by all existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels. Several notable individual investors, including 23andMe’s Co-founder and CEO Anne Wojcicki, former Netflix Chief Pro
36
Databridgemarketresearch.com added a new study on Artificial Intelligence Market Research Review 2020 that has been just made available providing an extensive knowledge and perceptions of the industry. This research report assists the consumer to figure out the actual outcomes of significant market players. It is a thorough study of new advances and expectancy in the market. The Artificial Intelligence Market report aims to discover the technological advancements and investment opportunities in the market. It has an intellectual glare that offers authentic details regarding developing trends, economical and industrial policies, region wise industry formation, profitability and downside of company product. This research report aid investors and organization to comprehend a scene of commercial progress and attributes of the market.
North America Artificial Intelligence in Healthcare Diagnosis Market To Witness Massive Growth Of US$ 32,009 61 million By 2027 With A CAGR Of 44 3% texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Maverick Medical AI Announces Elad Benjamin joins Board of Directors
USA - English
Share this article
Share this article
TEL AVIV, Israel, Jan. 25, 2021 /PRNewswire/ Maverick Medical AI announces the addition of Elad Benjamin to its Board of Directors. Elad brings over 20 years of executive-level experience in the Healthcare & Enterprise Software industry. During his career, Elad has held management roles in leading corporations such as Carestream Health and Lumenis, as well as in early-stage startups. As Co-Founder and CEO of Zebra Medical Vision, Elad led the company s growth including raising investment totaling $50 million. Elad currently serves as General Manager Radiology and AI Informatics at Philips.